|
Originally published In Press as doi:10.1074/jbc.M206942200 on November 8, 2002
J. Biol. Chem., Vol. 278, Issue 3, 1647-1655, January 17, 2003
Construction of a Deep-rough Mutant of Burkholderia
cepacia ATCC 25416 and Characterization of Its Chemical and
Biological Properties*
Sabine
Gronow §,
Christian
Noah ,
Antje
Blumenthal¶,
Buko
Lindner , and
Helmut
Brade
From the Divisions of Medical and Biochemical
Microbiology, ¶ Molecular Infection Biology, and
Biophysics, Research Center Borstel, Center for Medicine and
Biosciences, Parkallee 22, D-23845 Borstel, Germany
Burkholderia cepacia is a bacterium
with increasing importance as a pathogen in patients with cystic
fibrosis. The deep-rough mutant Ko2b was generated from B. cepacia type strain ATCC 25416 by insertion of a kanamycin
resistance cassette into the gene waaC encoding
heptosyltransferase I. Mass spectrometric analysis of the
de-O-acylated lipopolysaccharide (LPS) of the mutant showed that it consisted of a bisphosphorylated glucosamine backbone with two
3-hydroxyhexadecanoic acids in amide-linkage, 4-amino-4-deoxyarabinose (Ara4N) residues on both phosphates, and a core oligosaccharide of the
sequence Ara4N-(1 8)
D-glycero-D-talo-oct-2-ulosonic acid
(Ko)-(2 4)3-deoxy-D-manno-oct-2-ulosonic
acid (Kdo). The mutant allowed investigations on the biosynthesis of
the LPS as well as on its role in human infection. Mutant Ko2b showed
no difference in its ability to invade human macrophages as compared with the wild type. Furthermore, isolated LPS of both strains induced the production of tumor necrosis factor from macrophages to
the same extent. Thus, the truncation of the LPS did not decrease the
biological activity of the mutant or its LPS in these aspects.
*
This work was supported by Deutsche Forschungsgemeinschaft
Grants SFB 470/A1 (to H. B. and S. G.) and LI 448/1-1 (to B. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ302064 and AJ420777.
§
To whom correspondence should be addressed: Division of Medical and
Biochemical Microbiology Research Center Borstel, Center for Medicine
and Biosciences, Parkallee 22, D-23845 Borstel, Germany. Tel.:
49-4537-188469; Fax: 49-4537-188419; E-mail:
sgronow@fz-borstel.de.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro
Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides
Innate Immunity,
June 1, 2008;
14(3):
127 - 144.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
X. P. Ortega, S. T. Cardona, A. R. Brown, S. A. Loutet, R. S. Flannagan, D. J. Campopiano, J. R. W. Govan, and M. A. Valvano
A Putative Gene Cluster for Aminoarabinose Biosynthesis Is Essential for Burkholderia cenocepacia Viability
J. Bacteriol.,
May 1, 2007;
189(9):
3639 - 3644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Loutet, R. S. Flannagan, C. Kooi, P. A. Sokol, and M. A. Valvano
A Complete Lipopolysaccharide Inner Core Oligosaccharide Is Required for Resistance of Burkholderia cenocepacia to Antimicrobial Peptides and Bacterial Survival In Vivo
J. Bacteriol.,
March 15, 2006;
188(6):
2073 - 2080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gronow, W. Brabetz, B. Lindner, and H. Brade
OpsX from Haemophilus influenzae Represents a Novel Type of Heptosyltransferase I in Lipopolysaccharide Biosynthesis
J. Bacteriol.,
September 1, 2005;
187(17):
6242 - 6247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Silipo, A. Molinaro, P. Cescutti, E. Bedini, R. Rizzo, M. Parrilli, and R. Lanzetta
Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide
Glycobiology,
May 1, 2005;
15(5):
561 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shimomura, M. Matsuura, S. Saito, Y. Hirai, Y. Isshiki, and K. Kawahara
Unusual Interaction of a Lipopolysaccharide Isolated from Burkholderia cepacia with Polymyxin B
Infect. Immun.,
September 1, 2003;
71(9):
5225 - 5230.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|